An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacy SYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR ...
Almost everyone who lost their source of income (fully or partially) was eligible for the CERB. It’s inclusivity, and “fewer-questions-asked” policy made it one of the most sought after benefit ...
NORWOOD, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) (“Corbus” or the “Company”), announced that data from its US and UK conducted first-in-human dose ...
The CERB has ended, and it’s being replaced by the EI and the CRB. While it’s designed for people who don’t qualify for the EI, it might be serving people beyond its scope. Almost everyone who lost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback